tosho
20.06.08, 18:31
Już kiedyś było o tym na forum, ale wklejam raz jeszcze.
Jest to o klindamycynie - formie dożylnej i doustnej.
(praktyka dr-a Jemseka jemsekspecialty.com/files/DetailedLymeOverview.pdf )
The use of IV clindamycin has now become routine in our treatment protocol for
advanced neuroborreliosis. This change came about after we began using oral
clindamycin (with mepron) empirically for suspected cases of babesiosis
coinfection in our most recalcitrant, unresponsive patients. We immediately
noted some new and positive developments, e.g. absence of fever and night
sweats for the first time in months/years, increased mental acuity, and so
forth. Other patients had Herxheimer reactions that they had not experienced
for weeks on prior therapy, even though we were treating aggressively with
both intravenous and oral antibiotics.
Since our most debilitated patients were already on IV therapy, we decided to
try short courses of IV clindamycin and the effect has been consistently
impressive, even more so than with the oral formulation. We have now gone back
and retreated those patients who have had an incomplete response to prolonged
IV therapy, and in 11/12 of these cases, improvement on IV Clindamycin has
been dramatic. We are currently in the process of evaluating the optimal use
of clindamycin, as we continually do with all of the therapies we employ. Our
hope is that these more intensive therapeutic programs still provided in such
a way that they are tolerated, will allow us to shorten the IV program by
hastening the time to clinical improvement.